MGraphDTA: deep multiscale graph neural network for explainable drug–target binding affinity prediction

Ziduo Yang,Weihe Zhong,Lu Zhao,Calvin Yu-Chian Chen

DOI: https://doi.org/10.1039/d1sc05180f

IF: 8.4

2022-01-01

Chemical Science

Abstract:MGraphDTA is designed to capture the local and global structure of a compound simultaneously for drug–target affinity prediction and can provide explanations that are consistent with pharmacologists.

What problem does this paper attempt to address?

MvGraphDTA: multi-view-based graph deep model for drug-target affinity prediction by introducing the graphs and line graphs

Xin Zeng,Kai-Yang Zhong,Pei-Yan Meng,Shu-Juan Li,Shuang-Qing Lv,Meng-Liang Wen,Yi Li

DOI: https://doi.org/10.1186/s12915-024-01981-3

2024-08-26

Abstract:Background: Accurately identifying drug-target affinity (DTA) plays a pivotal role in drug screening, design, and repurposing in pharmaceutical industry. It not only reduces the time, labor, and economic costs associated with biological experiments but also expedites drug development process. However, achieving the desired level of computational accuracy for DTA identification methods remains a significant challenge. Results: We proposed a novel multi-view-based graph deep model known as MvGraphDTA for DTA prediction. MvGraphDTA employed a graph convolutional network (GCN) to extract the structural features from original graphs of drugs and targets, respectively. It went a step further by constructing line graphs with edges as vertices based on original graphs of drugs and targets. GCN was also used to extract the relationship features within their line graphs. To enhance the complementarity between the extracted features from original graphs and line graphs, MvGraphDTA fused the extracted multi-view features of drugs and targets, respectively. Finally, these fused features were concatenated and passed through a fully connected (FC) network to predict DTA. Conclusions: During the experiments, we performed data augmentation on all the training sets used. Experimental results showed that MvGraphDTA outperformed the competitive state-of-the-art methods on benchmark datasets for DTA prediction. Additionally, we evaluated the universality and generalization performance of MvGraphDTA on additional datasets. Experimental outcomes revealed that MvGraphDTA exhibited good universality and generalization capability, making it a reliable tool for drug-target interaction prediction.
Multidta: drug-target binding affinity prediction via representation learning and graph convolutional neural networks

Jiejin Deng,Yijia Zhang,Yaohua Pan,Xiaobo Li,Mingyu Lu

DOI: https://doi.org/10.1007/s13042-023-02058-3

2024-01-11

International Journal of Machine Learning and Cybernetics

Abstract:The prediction of Drug-Target Interactions (DTI) plays a pivotal role in drug repositioning research. While recent years have witnessed the proliferation of neural network-based methods for Drug-Target Affinity (DTA) prediction, existing models predominantly rely on either sequence-based or graph-based approaches to model drug-target pairs. This limitation obstructs models from harnessing more valuable information from various data sources for downstream predictions. To overcome this constraint, this paper introduces an innovative end-to-end learning framework for DTA prediction, named MultiDTA. Firstly, we construct four channels tailored to comprehensively mine representations embedded within drug-target pair sequences and model them through graph structures to learn spatial structural information. Secondly, after capturing latent high-level representations from different data structures across these four channels, we employ an attention mechanism to discern each channel's contributions to downstream tasks. Experimental results demonstrate that our proposed model surpasses sequence-based and graph-based methods, affirming our model's capacity to simultaneously capture high-level representations from multiple data structures. Furthermore, we enhance the model's interpretability by visualizing the contributions of these four channels using the attention mechanism. The code of MultiDTA and the relevant data are available at: https://github.com/dengjiejin/MultiDTA.

computer science, artificial intelligence
DGDTA: dynamic graph attention network for predicting drug-target binding affinity

Haixia Zhai,Hongli Hou,Junwei Luo,Xiaoyan Liu,Zhengjiang Wu,Junfeng Wang

DOI: https://doi.org/10.1186/s12859-023-05497-5

IF: 3.307

2023-09-30

BMC Bioinformatics

Abstract:Background: Obtaining accurate drug-target binding affinity (DTA) information is significant for drug discovery and drug repositioning. Although some methods have been proposed for predicting DTA, the features of proteins and drugs still need to be further analyzed. Recently, deep learning has been successfully used in many fields. Hence, designing a more effective deep learning method for predicting DTA remains attractive. Results: Dynamic graph DTA (DGDTA), which uses a dynamic graph attention network combined with a bidirectional long short-term memory (Bi-LSTM) network to predict DTA is proposed in this paper. DGDTA adopts drug compound as input according to its corresponding simplified molecular input line entry system (SMILES) and protein amino acid sequence. First, each drug is considered a graph of interactions between atoms and edges, and dynamic attention scores are used to consider which atoms and edges in the drug are most important for predicting DTA. Then, Bi-LSTM is used to better extract the contextual information features of protein amino acid sequences. Finally, after combining the obtained drug and protein feature vectors, the DTA is predicted by a fully connected layer. The source code is available from GitHub at https://github.com/luojunwei/DGDTA . Conclusions: The experimental results show that DGDTA can predict DTA more accurately than some other methods.
AttentionMGT-DTA: A multi-modal drug-target affinity prediction using graph transformer and attention mechanism

Hongjie Wu,Junkai Liu,Tengsheng Jiang,Quan Zou,Shujie Qi,Zhiming Cui,Prayag Tiwari,Yijie Ding

DOI: https://doi.org/10.1016/j.neunet.2023.11.018

IF: 7.8

2024-01-01

Neural Networks

Abstract:The accurate prediction of drug-target affinity (DTA) is a crucial step in drug discovery and design. Traditional experiments are very expensive and time-consuming. Recently, deep learning methods have achieved notable performance improvements in DTA prediction. However, one challenge for deep learning-based models is appropriate and accurate representations of drugs and targets, especially the lack of effective exploration of target representations. Another challenge is how to comprehensively capture the interaction information between different instances, which is also important for predicting DTA. In this study, we propose AttentionMGT-DTA, a multi-modal attention-based model for DTA prediction. AttentionMGT-DTA represents drugs and targets by a molecular graph and binding pocket graph, respectively. Two attention mechanisms are adopted to integrate and interact information between different protein modalities and drug-target pairs. The experimental results showed that our proposed model outperformed state-of-the-art baselines on two benchmark datasets. In addition, AttentionMGT-DTA also had high interpretability by modeling the interaction strength between drug atoms and protein residues. Our code is available at https://github.com/JK-Liu7/AttentionMGT-DTA.

computer science, artificial intelligence,neurosciences
Drug–target affinity prediction with extended graph learning-convolutional networks

Haiou Qi,Ting Yu,Wenwen Yu,Chenxi Liu

DOI: https://doi.org/10.1186/s12859-024-05698-6

IF: 3.307

2024-02-19

BMC Bioinformatics

Abstract:High-performance computing plays a pivotal role in computer-aided drug design, a field that holds significant promise in pharmaceutical research. The prediction of drug–target affinity (DTA) is a crucial stage in this process, potentially accelerating drug development through rapid and extensive preliminary compound screening, while also minimizing resource utilization and costs. Recently, the incorporation of deep learning into DTA prediction and the enhancement of its accuracy have emerged as key areas of interest in the research community. Drugs and targets can be characterized through various methods, including structure-based, sequence-based, and graph-based representations. Despite the progress in structure and sequence-based techniques, they tend to provide limited feature information. Conversely, graph-based approaches have risen to prominence, attracting considerable attention for their comprehensive data representation capabilities. Recent studies have focused on constructing protein and drug molecular graphs using sequences and SMILES, subsequently deriving representations through graph neural networks. However, these graph-based approaches are limited by the use of a fixed adjacent matrix of protein and drug molecular graphs for graph convolution. This limitation restricts the learning of comprehensive feature representations from intricate compound and protein structures, consequently impeding the full potential of graph-based feature representation in DTA prediction. This, in turn, significantly impacts the models' generalization capabilities in the complex realm of drug discovery.

biochemical research methods,biotechnology & applied microbiology,mathematical & computational biology
GraphDTA: predicting drug-target binding affinity with graph neural networks

Thin Nguyen,Hang Le,Thomas P Quinn,Tri Nguyen,Thuc Duy Le,Svetha Venkatesh

DOI: https://doi.org/10.1093/bioinformatics/btaa921

IF: 5.8

2021-05-23

Bioinformatics

Abstract:Summary: The development of new drugs is costly, time consuming and often accompanied with safety issues. Drug repurposing can avoid the expensive and lengthy process of drug development by finding new uses for already approved drugs. In order to repurpose drugs effectively, it is useful to know which proteins are targeted by which drugs. Computational models that estimate the interaction strength of new drug-target pairs have the potential to expedite drug repurposing. Several models have been proposed for this task. However, these models represent the drugs as strings, which is not a natural way to represent molecules. We propose a new model called GraphDTA that represents drugs as graphs and uses graph neural networks to predict drug-target affinity. We show that graph neural networks not only predict drug-target affinity better than non-deep learning models, but also outperform competing deep learning methods. Our results confirm that deep learning models are appropriate for drug-target binding affinity prediction, and that representing drugs as graphs can lead to further improvements. Availability of implementation: The proposed models are implemented in Python. Related data, pre-trained models and source code are publicly available at https://github.com/thinng/GraphDTA. All scripts and data needed to reproduce the post hoc statistical analysis are available from https://doi.org/10.5281/zenodo.3603523. Supplementary information: Supplementary data are available at Bioinformatics online.
GSAML-DTA: An interpretable drug-target binding affinity prediction model based on graph neural networks with self-attention mechanism and mutual information

Jiaqi Liao,Haoyang Chen,Lesong Wei,Leyi Wei,Jiaqi Liao,Haoyang Chen,Lesong Wei,Leyi Wei

DOI: https://doi.org/10.1016/j.compbiomed.2022.106145

IF: 7.7

2022-11-01

Computers in Biology and Medicine

Abstract:Identifying drug-target affinity (DTA) has great practical importance in the process of designing efficacious drugs for known diseases. Recently, numerous deep learning-based computational methods have been developed to predict drug-target affinity and achieved impressive performance. However, most of them construct the molecule (drug or target) encoder without considering the weights of features of each node (atom or residue). Besides, they generally combine drug and target representations directly, which may contain irrelevant-task information. In this study, we develop GSAML-DTA, an interpretable deep learning framework for DTA prediction. GSAML-DTA integrates a self-attention mechanism and graph neural networks (GNNs) to build representations of drugs and target proteins from the structural information. In addition, mutual information is introduced to filter out redundant information and retain relevant information in the combined representations of drugs and targets. Extensive experimental results demonstrate that GSAML-DTA outperforms state-of-the-art methods for DTA prediction on two benchmark datasets. Furthermore, GSAML-DTA has the interpretation ability to analyze binding atoms and residues, which may be conducive to chemical biology studies from data. Overall, GSAML-DTA can serve as a powerful and interpretable tool suitable for DTA modelling.

engineering, biomedical,computer science, interdisciplinary applications,mathematical & computational biology,biology
MSGNN-DTA: Multi-Scale Topological Feature Fusion Based on Graph Neural Networks for Drug–Target Binding Affinity Prediction

Shudong Wang,Xuanmo Song,Yuanyuan Zhang,Kuijie Zhang,Yingye Liu,Chuanru Ren,Shanchen Pang

DOI: https://doi.org/10.3390/ijms24098326

IF: 5.6

2023-05-05

International Journal of Molecular Sciences

Abstract:The accurate prediction of drug–target binding affinity (DTA) is an essential step in drug discovery and drug repositioning. Although deep learning methods have been widely adopted for DTA prediction, the complexity of extracting drug and target protein features hampers the accuracy of these predictions. In this study, we propose a novel model for DTA prediction named MSGNN-DTA, which leverages a fused multi-scale topological feature approach based on graph neural networks (GNNs). To address the challenge of accurately extracting drug and target protein features, we introduce a gated skip-connection mechanism during the feature learning process to fuse multi-scale topological features, resulting in information-rich representations of drugs and proteins. Our approach constructs drug atom graphs, motif graphs, and weighted protein graphs to fully extract topological information and provide a comprehensive understanding of underlying molecular interactions from multiple perspectives. Experimental results on two benchmark datasets demonstrate that MSGNN-DTA outperforms the state-of-the-art models in all evaluation metrics, showcasing the effectiveness of the proposed approach. Moreover, the study conducts a case study based on already FDA-approved drugs in the DrugBank dataset to highlight the potential of the MSGNN-DTA framework in identifying drug candidates for specific targets, which could accelerate the process of virtual screening and drug repositioning.

biochemistry & molecular biology,chemistry, multidisciplinary
NHGNN-DTA: a node-adaptive hybrid graph neural network for interpretable drug–target binding affinity prediction

Haohuai He,Guanxing Chen,Calvin Yu-Chian Chen

DOI: https://doi.org/10.1093/bioinformatics/btad355

IF: 5.8

2023-05-30

Bioinformatics

Abstract:Abstract Motivation Large-scale prediction of drug–target affinity (DTA) plays an important role in drug discovery. In recent years, machine learning algorithms have made great progress in DTA prediction by utilizing sequence or structural information of both drugs and proteins. However, sequence-based algorithms ignore the structural information of molecules and proteins, while graph-based algorithms are insufficient in feature extraction and information interaction. Results In this article, we propose NHGNN-DTA, a node-adaptive hybrid neural network for interpretable DTA prediction. It can adaptively acquire feature representations of drugs and proteins and allow information to interact at the graph level, effectively combining the advantages of both sequence-based and graph-based approaches. Experimental results have shown that NHGNN-DTA achieved new state-of-the-art performance. It achieved the mean squared error (MSE) of 0.196 on the Davis dataset (below 0.2 for the first time) and 0.124 on the KIBA dataset (3% improvement). Meanwhile, in the case of cold start scenario, NHGNN-DTA proved to be more robust and more effective with unseen inputs than baseline methods. Furthermore, the multi-head self-attention mechanism endows the model with interpretability, providing new exploratory insights for drug discovery. The case study on Omicron variants of SARS-CoV-2 illustrates the efficient utilization of drug repurposing in COVID-19. Availability and implementation The source code and data are available at https://github.com/hehh77/NHGNN-DTA.

biochemical research methods,biotechnology & applied microbiology,mathematical & computational biology
Hierarchical graph representation learning for the prediction of drug-target binding affinity

Zhaoyang Chu,Feng Huang,Haitao Fu,Yuan Quan,Xionghui Zhou,Shichao Liu,Wen Zhang

DOI: https://doi.org/10.1016/j.ins.2022.09.043

IF: 8.1

2022-10-01

Information Sciences

Abstract:Computationally predicting drug-target binding affinity (DTA) has attracted increasing attention due to its benefit for accelerating drug discovery. Currently, numerous deep learning-based prediction models have been proposed, often with a biencoder architecture that commonly focuses on how to extract expressive representations for drugs and targets but overlooks modeling explicit drug-target interactions. However, known DTA can provide underlying knowledge about how the drugs interact with targets that is beneficial for predictive accuracy. In this paper, we propose a novel hierarchical graph representation learning model for DTA prediction, named HGRL-DTA. The main contribution of our model is to establish a hierarchical graph learning architecture to integrate the coarse- and fine-level information from an affinity graph and drug/target molecule graphs, respectively, in a well-designed coarse-to-fine manner. In addition, we design a similarity-based representation inference method to infer coarse-level information when it is unavailable for new drugs or targets under the cold start scenario. Comprehensive experimental results under four scenarios across two benchmark datasets indicate that HGRL-DTA outperforms the state-of-the-art models in almost all cases.

computer science, information systems
SubMDTA: drug target affinity prediction based on substructure extraction and multi-scale features

Shourun Pan,Leiming Xia,Lei Xu,Zhen Li

DOI: https://doi.org/10.1186/s12859-023-05460-4

IF: 3.307

2023-09-09

BMC Bioinformatics

Abstract:Drug–target affinity (DTA) prediction is a critical step in the field of drug discovery. In recent years, deep learning-based methods have emerged for DTA prediction. In order to solve the problem of fusion of substructure information of drug molecular graphs and utilize multi-scale information of protein, a self-supervised pre-training model based on substructure extraction and multi-scale features is proposed in this paper.

biochemical research methods,biotechnology & applied microbiology,mathematical & computational biology
MMD-DTA: A multi-modal deep learning framework for drug-target binding affinity and binding region prediction

Qi Zhang,Yuxiao Wei,Bo Liao,Liwei Liu,Shengli Zhang

DOI: https://doi.org/10.1109/TCBB.2024.3451985

2024-08-29

Abstract:The prediction of drug-target affinity (DTA) plays a crucial role in drug development and the identification of potential drug targets. In recent years, computer-assisted DTA prediction has emerged as a significant approach in this field. In this study, we propose a multi-modal deep learning framework called MMD-DTA for predicting drug-target binding affinity and binding regions. The model can predict DTA while simultaneously learning the binding regions of drug-target interactions through unsupervised learning. To achieve this, MMD-DTA first uses graph neural networks and target structural feature extraction network to extract multi-modal information from the sequences and structures of drugs and targets. It then utilizes the feature interaction and fusion modules to generate interaction descriptors for predicting DTA and interaction strength for binding region prediction. Our experimental results demonstrate that MMD-DTA outperforms existing models based on key evaluation metrics. Furthermore, external validation results indicate that MMD-DTA enhances the generalization capability of the model by integrating sequence and structural information of drugs and targets. The model trained on the benchmark dataset can effectively generalize to independent virtual screening tasks. The visualization of drug-target binding region prediction showcases the interpretability of MMD-DTA, providing valuable insights into the functional regions of drug molecules that interact with proteins.
Drug–target binding affinity prediction based on three-branched multiscale convolutional neural networks

Yaoyao Lu,Junkai Liu,Tengsheng Jiang,Zhiming Cui,Hongjie Wu

DOI: https://doi.org/10.2174/1574893618666230816090548

2023-08-16

Current Bioinformatics

Abstract:Background: New drugs are costly, time-consuming, and often accompanied by safety concerns. With the development of deep learning, computer-aided drug design has become more mainstream, and convolutional neural networks and graph neural networks have been widely used for drug–target affinity (DTA) prediction. Objective: The paper proposes a method of predicting DTA using graph convolutional networks and multiscale convolutional neural networks. Methods: We construct drug molecules into graph representation vectors and learn feature expressions through graph attention networks and graph convolutional networks. A three-branch convolutional neural network learns the local and global features of protein sequences, and the two feature representations are merged into a regression module to predict the DTA. Results: We present a novel model to predict DTA, with a 2.5% improvement in the consistency index and a 21% accuracy improvement in terms of the mean squared error on the Davis dataset compared to DeepDTA. Morever, our method outperformed other mainstream DTA prediction models namely, GANsDTA, WideDTA, GraphDTA and DeepAffinity. Conclusion: The results showed that the use of multiscale convolutional neural networks was better than a single-branched convolutional neural network at capturing protein signatures and the use of graphs to express drug molecules yielded better results.

biochemical research methods,mathematical & computational biology
HiGraphDTI: Hierarchical Graph Representation Learning for Drug-Target Interaction Prediction

Bin Liu,Siqi Wu,Jin Wang,Xin Deng,Ao Zhou

2024-04-16

Abstract:The discovery of drug-target interactions (DTIs) plays a crucial role in pharmaceutical development. The deep learning model achieves more accurate results in DTI prediction due to its ability to extract robust and expressive features from drug and target chemical structures. However, existing deep learning methods typically generate drug features via aggregating molecular atom representations, ignoring the chemical properties carried by motifs, i.e., substructures of the molecular graph. The atom-drug double-level molecular representation learning can not fully exploit structure information and fails to interpret the DTI mechanism from the motif perspective. In addition, sequential model-based target feature extraction either fuses limited contextual information or requires expensive computational resources. To tackle the above issues, we propose a hierarchical graph representation learning-based DTI prediction method (HiGraphDTI). Specifically, HiGraphDTI learns hierarchical drug representations from triple-level molecular graphs to thoroughly exploit chemical information embedded in atoms, motifs, and molecules. Then, an attentional feature fusion module incorporates information from different receptive fields to extract expressive target features.Last, the hierarchical attention mechanism identifies crucial molecular segments, which offers complementary views for interpreting interaction mechanisms. The experiment results not only demonstrate the superiority of HiGraphDTI to the state-of-the-art methods, but also confirm the practical ability of our model in interaction interpretation and new DTI discovery.

Machine Learning,Quantitative Methods
A deep learning method for drug-target affinity prediction based on sequence interaction information mining

Mingjian Jiang,Yunchang Shao,Yuanyuan Zhang,Wei Zhou,Shunpeng Pang

DOI: https://doi.org/10.7717/peerj.16625

IF: 3.061

2023-12-11

PeerJ

Abstract:Background: A critical aspect of in silico drug discovery involves the prediction of drug-target affinity (DTA). Conducting wet lab experiments to determine affinity is both expensive and time-consuming, making it necessary to find alternative approaches. In recent years, deep learning has emerged as a promising technique for DTA prediction, leveraging the substantial computational power of modern computers. Methods: We proposed a novel sequence-based approach, named KC-DTA, for predicting drug-target affinity (DTA). In this approach, we converted the target sequence into two distinct matrices, while representing the molecule compound as a graph. The proposed method utilized k-mers analysis and Cartesian product calculation to capture the interactions and evolutionary information among various residues, enabling the creation of the two matrices for target sequence. For molecule, it was represented by constructing a molecular graph where atoms serve as nodes and chemical bonds serve as edges. Subsequently, the obtained target matrices and molecule graph were utilized as inputs for convolutional neural networks (CNNs) and graph neural networks (GNNs) to extract hidden features, which were further used for the prediction of binding affinity. Results: In order to evaluate the effectiveness of the proposed method, we conducted several experiments and made a comprehensive comparison with the state-of-the-art approaches using multiple evaluation metrics. The results of our experiments demonstrated that the KC-DTA method achieves high performance in predicting drug-target affinity (DTA). The findings of this research underscore the significance of the KC-DTA method as a valuable tool in the field of in silico drug discovery, offering promising opportunities for accelerating the drug development process. All the data and code are available for access on https://github.com/syc2017/KCDTA.
Drug-Target Affinity Prediction Based on Improved GraphDTA

Leiluo Wang,Shukai Jiang,Xiangyang Chen,Zi Ye

DOI: https://doi.org/10.1109/ICRCV59470.2023.10329187

2023-09-15

Abstract:The development of new drugs is costly, time-consuming, and high-risk. Drug repurposing is a strategy that can avoid the expensive and lengthy drug development process. To achieve effective drug repurposing, understanding which proteins are targets of which drugs is a crucial issue. Predicting drug-target affinity using computational models can accelerate drug repurposing. However, many existing computational models represent drugs as strings, which are not the optimal representation of molecules. In GraphDTA, the SMIILES encoding of molecules is converted into a two-dimensional molecular graph, and a graph neural network is used to better learn the features of molecules. This article improves the GraphDTA model and proposes two methods to further enhance the model’s performance. Firstly, a multi-scale feature fusion mechanism is introduced in the GIN model, which can better capture the structural information and chemical features of molecules, improving the accuracy of the model. Secondly, we propose a method that combines GIN and GAT. By concatenating the GIN and GAT models, a more comprehensive and accurate graph representation can be obtained, improving the model’s predictive performance. The model is evaluated using the Davis dataset, and the results show that the proposed model outperforms the original model, demonstrating the effectiveness of this method and its potential for a wide range of applications.

Computer Science,Medicine,Chemistry
An Adaptive Graph Learning Method for Automated Molecular Interactions and Properties Predictions

Yuquan Li,Chang-Yu Hsieh,Ruiqiang Lu,Xiaoqing Gong,Xiaorui Wang,Pengyong Li,Shuo Liu,Yanan Tian,Dejun Jiang,Jiaxian Yan,Qifeng Bai,Huanxiang Liu,Shengyu Zhang,Xiaojun Yao

DOI: https://doi.org/10.1038/s42256-022-00501-8

IF: 23.8

2022-01-01

Nature Machine Intelligence

Abstract:Improving drug discovery efficiency is a core and long-standing challenge in drug discovery. For this purpose, many graph learning methods have been developed to search potential drug candidates with fast speed and low cost. In fact, the pursuit of high prediction performance on a limited number of datasets has crystallized their architectures and hyperparameters, making them lose advantage in repurposing to new data generated in drug discovery. Here we propose a flexible method that can adapt to any dataset and make accurate predictions. The proposed method employs an adaptive pipeline to learn from a dataset and output a predictor. Without any manual intervention, the method achieves far better prediction performance on all tested datasets than traditional methods, which are based on hand-designed neural architectures and other fixed items. In addition, we found that the proposed method is more robust than traditional methods and can provide meaningful interpretability. Given the above, the proposed method can serve as a reliable method to predict molecular interactions and properties with high adaptability, performance, robustness and interpretability. This work takes a solid step forward to the purpose of aiding researchers to design better drugs with high efficiency. Deep learning methods can provide useful predictions for drug design, but their hyperparameters need to be carefully tweaked to give good performance on a specific problem or dataset. Li et al. present here a method that finds appropriate architectures and hyperparameters for a wide range of drug design tasks and can achieve good performance without human intervention.
A survey of drug-target interaction and affinity prediction methods via graph neural networks

Yue Zhang,Yuqing Hu,Na Han,Aqing Yang,Xiaoyong Liu,Hongmin Cai

DOI: https://doi.org/10.1016/j.compbiomed.2023.107136

IF: 7.7

2023-06-08

Computers in Biology and Medicine

Abstract:The tasks of drug-target interaction (DTI) and drug-target affinity (DTA) prediction play important roles in the field of drug discovery. However, biological experiment-based methods are time-consuming and expensive. Recently, computational-based approaches have accelerated the process of drug-target relationship prediction. Drug and target features are represented in structure-based, sequence-based, and graph-based ways. Although some achievements have been made regarding structure-based representations and sequence-based representations, the acquired feature information is not sufficiently rich. Molecular graph-based representations are some of the more popular approaches, and they have also generated a great deal of interest. In this article, we provide an overview of the DTI prediction and DTA prediction tasks based on graph neural networks (GNNs). We briefly discuss the molecular graphs of drugs, the primary sequences of target proteins, and the graph reSLBpresentations of target proteins. Meanwhile, we conducted experiments on various fundamental datasets to substantiate the plausibility of DTI and DTA utilizing graph neural networks.

engineering, biomedical,computer science, interdisciplinary applications,mathematical & computational biology,biology
HGTDP-DTA: Hybrid Graph-Transformer with Dynamic Prompt for Drug-Target Binding Affinity Prediction

Xi Xiao,Wentao Wang,Jiacheng Xie,Lijing Zhu,Gaofei Chen,Zhengji Li,Tianyang Wang,Min Xu

2024-06-26

Abstract:Drug target binding affinity (DTA) is a key criterion for drug screening. Existing experimental methods are time-consuming and rely on limited structural and domain information. While learning-based methods can model sequence and structural information, they struggle to integrate contextual data and often lack comprehensive modeling of drug-target interactions. In this study, we propose a novel DTA prediction method, termed HGTDP-DTA, which utilizes dynamic prompts within a hybrid Graph-Transformer framework. Our method generates context-specific prompts for each drug-target pair, enhancing the model's ability to capture unique interactions. The introduction of prompt tuning further optimizes the prediction process by filtering out irrelevant noise and emphasizing task-relevant information, dynamically adjusting the input features of the molecular graph. The proposed hybrid Graph-Transformer architecture combines structural information from Graph Convolutional Networks (GCNs) with sequence information captured by Transformers, facilitating the interaction between global and local information. Additionally, we adopted the multi-view feature fusion method to project molecular graph views and affinity subgraph views into a common feature space, effectively combining structural and contextual information. Experiments on two widely used public datasets, Davis and KIBA, show that HGTDP-DTA outperforms state-of-the-art DTA prediction methods in both prediction performance and generalization ability.

Machine Learning,Artificial Intelligence,Computer Vision and Pattern Recognition
SSR-DTA: Substructure-aware multi-layer graph neural networks for drug-target binding affinity prediction

Yuansheng Liu,Xinyan Xia,Yongshun Gong,Bosheng Song,Xiangxiang Zeng

DOI: https://doi.org/10.1016/j.artmed.2024.102983

Abstract:Accurate prediction of drug-target binding affinity (DTA) is essential in the field of drug discovery. Recently, scientists have been attempting to utilize artificial intelligence prediction to screen out a significant number of ineffective compounds, thereby mitigating labor and financial losses. While graph neural networks (GNNs) have been applied to DTA, existing GNNs have limitations in effectively extracting substructural features across various sizes. Functional groups play a crucial role in modulating molecular properties, but existing GNNs struggle with feature extraction from certain motifs due to scale mismatches. Additionally, sequence-based models for target proteins lack the integration of structural information. To address these limitations, we present SSR-DTA, a multi-layer graph network capable of adapting to diverse structural sizes, which can extract richer biological features, thereby improving the robustness and accuracy of predictions. Multi-layer GNNs enable the capture of molecular motifs across different scales, ranging from atomic to macrocyclic motifs. Furthermore, we introduce BiGNN to simultaneously learn sequence and structural information. Sequence information corresponds to the primary structure of proteins, while graph information represents the tertiary structure. BiGNN assimilates richer information compared to sequence-based methods while mitigating the impact of errors from predicted structures, resulting in more accurate predictions. Through rigorous experimental evaluations conducted on four benchmark datasets, we demonstrate the superiority of SSR-DTA over state-of-the-art models. Particularly, in comparison to state-of-the-art models, SSR-DTA demonstrates an impressive 20% reduction in mean squared error on the Davis dataset and a 5% reduction on the KIBA dataset, underscoring its potential as a valuable tool for advancing DTA prediction.

MGraphDTA: deep multiscale graph neural network for explainable drug–target binding affinity prediction

MvGraphDTA: multi-view-based graph deep model for drug-target affinity prediction by introducing the graphs and line graphs

Multidta: drug-target binding affinity prediction via representation learning and graph convolutional neural networks

DGDTA: dynamic graph attention network for predicting drug-target binding affinity

AttentionMGT-DTA: A multi-modal drug-target affinity prediction using graph transformer and attention mechanism

Drug–target affinity prediction with extended graph learning-convolutional networks

GraphDTA: predicting drug-target binding affinity with graph neural networks

GSAML-DTA: An interpretable drug-target binding affinity prediction model based on graph neural networks with self-attention mechanism and mutual information

MSGNN-DTA: Multi-Scale Topological Feature Fusion Based on Graph Neural Networks for Drug–Target Binding Affinity Prediction

NHGNN-DTA: a node-adaptive hybrid graph neural network for interpretable drug–target binding affinity prediction

Hierarchical graph representation learning for the prediction of drug-target binding affinity

SubMDTA: drug target affinity prediction based on substructure extraction and multi-scale features

MMD-DTA: A multi-modal deep learning framework for drug-target binding affinity and binding region prediction

Drug–target binding affinity prediction based on three-branched multiscale convolutional neural networks

HiGraphDTI: Hierarchical Graph Representation Learning for Drug-Target Interaction Prediction

A deep learning method for drug-target affinity prediction based on sequence interaction information mining

Drug-Target Affinity Prediction Based on Improved GraphDTA

An Adaptive Graph Learning Method for Automated Molecular Interactions and Properties Predictions

A survey of drug-target interaction and affinity prediction methods via graph neural networks

HGTDP-DTA: Hybrid Graph-Transformer with Dynamic Prompt for Drug-Target Binding Affinity Prediction

SSR-DTA: Substructure-aware multi-layer graph neural networks for drug-target binding affinity prediction